CryoLife to Present at 18th Annual Needham Healthcare Conference
Get Alerts CRY Hot Sheet
Join SI Premium – FREE
ATLANTA, April 3, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Needham Healthcare Conference on Wednesday, April 10, 2019 at the Westin Grand Central hotel in New York.

A live webcast of the Company's presentation is scheduled to begin at 10:00 a.m. ET and will feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive Officer.
The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website.
About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.
Contacts: | |
CryoLife D. Ashley Lee Executive Vice President, Chief Financial Officerand Chief Operating OfficerPhone: 770-419-3355 | Gilmartin Group LLCGreg Chodaczek / Lynn LewisPhone: 646-924-1769[email protected] |
View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-18th-annual-needham-healthcare-conference-300823495.html
SOURCE CryoLife, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Tyler Family Law's Natalie Tyler Publishes Guide on Dekalb County Custody Modification
- Innovative Food Holdings, Inc. Reports Financial Results for Second Quarter of 2026
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share